Therapeutic Drug Monitoring of Prednisolone After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 25, Issue 5, 2006, Pages 557-563

  Morton, Judith M ^a,b   Williamson, Sharon ^b   Kear, Laurie M ^b   McWhinney, Brett C ^c   Potter, Julia ^b   Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; CALCITRIOL; CISAPRIDE; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PAMIDRONIC ACID; PREDNISOLONE; RAPAMYCIN; RIFAMPICIN; SIMVASTATIN; STEROID; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; STATISTICAL SIGNIFICANCE;

AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; POSTOPERATIVE PERIOD; PREDNISOLONE;

EID: 33646164425     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.11.460     Document Type: Article

References (40)

1. Charlebois J.E., Lum B.L., Cooney G.F., Mochon M., and Kaiser B.A. Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients. Ther Drug Monit 19 (1997) 277-280
2. Marsh C.L. Abbreviated pharmacokinetic profiles in area-under-the curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Ther Drug Monit 21 (1999) 27-34
3. Primmett D.R.N., Levine M., Kovarik J.M., Mueller E.A., and Keown P.A. Cyclosporine monitoring in patients with renal transplants. two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure. Ther Drug Monit 20 (1998) 276-283
4. Meier-Kriesche H.-U., Kaplan B., Brannan P., Kahan B.D., and Portman R.J. A limited sampling strategy for the estimation of eight-hour Neoral areas under the curve in renal transplantation. Ther Drug Monit 20 (1998) 401-407
5. David O.J., and Johnston A. Limited sampling strategies for estimating cyclosporin area under the concentration-curve. review of current algorithms. Ther Drug Monit 23 (2001) 100-114
6. Jeng S., Chanchairujira T., Jusko W., and Steiner R. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole. Transplantation 75 (2003) 792-795
7. Dove A.M., Szefler S.J., Hill M.R., et al. Altered prednisolone pharmacokinetics in patients with cystic fibrosis. J Pediatr 120 (1992) 789-794
8. Georgitis J.W., Flesher K.A., and Szefler S.J. Bioavailability assessment of a liquid prednisone preparation. J Allergy Clin Immunol 70 (1982) 243-247
9. Bergrem H., Jervell J., and Flatmark A. Prednisolone pharmacokinetics in cushingoid and noncushingoid kidney transplant patients. Kidney Int 27 (1985) 459-464
10. Bergrem H., and Opedal I. Bioavailability of prednisolone in patients with intestinal malabsorption. the importance of measuring serum protein-binding. Scand J Gastroenterol 18 (1983) 545-549
11. Bergrem H., Ritland S., Opedal I., and Bergan A. Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt. Scand J Gastroenterol 18 (1983) 273-276
12. Potter J.M., McWhinney B.C., Sampson L., and Hickman P.E. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit 26 (2004) 408-414
13. Majid O., Akhlaghi F., Lee T., Holt D.W., and Trull A. Simultaneous determination of plasma prednisolone, prednisone, and cortisol levels by high-performance liquid chromatography. Ther Drug Monit 23 (2001) 163-168
14. 2 monitoring after lung transplantation. J Heart Lung Transplant 23 (2004) 1035-1039
15. 2 monitoring improves renal dysfunction after lung transplantation. J Heart Lung Transplant 23 (2004) 1170-1174
16. Trulock E.P., Edwards L.B., Taylor D.O., et al. The registry of the International Society for Heart and Lung Transplantation. twenty-first official adult lung and heart-lung transplant report-2004. J Heart Lung Transplant 23 (2004) 804-815
17. Boucek M.M., Edwards L.B., Keck B.M., et al. Registry for the International Society for Heart and Lung Transplantation. seventh official pediatric report-2004. J Heart Lung Transplant 23 (2004) 933-947
18. Taylor D.O., Edwards L.B., Boucek M.M., et al. The registry of the International Society for Heart and Lung Transplantation. twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 796-803
19. McWhinney B.C., Ward G., and Hickman P.E. Improved HPLC method for simultaneous analysis of cortisol, 11-deoxycortisol, prednisolone, methylprednisolone, and dexamethasone in serum and urine. Clin Chem 42 (1996) 979-981
20. Cooper J.D., Billingham M., Egan T., et al., International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
21. Green C.G., Kraus C.K., Lemanske R.F., Farrell P.M., and Jusko W.J. Rapid methylprednisolone clearance in a patient with cystic fibrosis. Drug Intell Clin Pharm 22 (1988) 876-878
22. Gerbase M.W., Fathi M., Spiliopoulos A., Rochat T., and Nicod L.P. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors. long-term monitoring in stable lung recipients with and without cystic fibrosis. J Heart Lung Transplant 22 (2003) 587-590
23. Dupuis R., and Sredzienski E.S. Tobramycin pharmacokinetics in patients with cystic fibrosis preceding and following lung transplantation. Ther Drug Monit 1999 (1999) 161-165
24. Boucek M.M., Faro A., Novick R.J., et al. The registry of the International Society for Heart and Lung Transplantation. fourth official pediatric report-2000. J Heart Lung Transplant 20 (2001) 39-52
25. Braith R.W., Howard C., Fricker F.J., Mitchell M., and Edwards D.G. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant 19 (2000) 840-845
26. Sheiner P.A., Magliocca J.F., Bodian C.A., et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 69 (2000) 781-789
27. Leidig-Bruckner G., Hosch S., Dodidou P., et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation. a follow-up study. Lancet 357 (2001) 342-347
28. Kauppila M., Irjala K., Koskinen P., et al. Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant 24 (1999) 885-889
29. Aris R.M., Neuringer I.P., Weiner M.A., Egan T.M., and Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 109 (1996) 1176-1183
30. Giannini S., Nobile M., Ciuffreda M., et al. Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos Int 11 (2000) 417-424
31. Kokado Y., Takahara S., Ichimaru N., et al. Factors influencing vertebral bone density after renal transplantation. Transplant Int 13 suppl 1 (2000) S431-S435
32. Ugur A., Guvener N., Isiklar I., et al. Osteoporosis after renal transplantation. single center experience. Transplantation 71 (2001) 645-649
33. Heaf J., Tvedegaard E., Kanstrup I.L., and Fogh-Andersen N. Bone loss after renal transplantation. role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14 (2000) 457-463
34. Caglar M., and Adeera L. Factors affecting bone mineral density in renal transplant patients. Ann Nucl Med 13 (1999) 141-145
35. Grotz W.H., Mundinger F.A., Rasenack J., et al. Bone loss after kidney transplantation. a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10 (1995) 2096-2100
36. Pichette V., Bonnardeaux A., Prudhomme L., et al. Long-term bone loss in kidney transplant recipients. a cross-sectional and longitudinal study. Am J Kidney Dis 28 (1996) 105-114
37. Schulte C., Beelen D.W., Schaefer U.W., and Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells. a prospective study. Osteoporos Int 11 (2000) 344-353
38. Trautwein C., Possienke M., Schlitt H.J., et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95 (2000) 2343-2351
39. Shane E., Rivas M.C., Silverberg S.J., et al. Osteoporosis after cardiac transplantation. Am J Med 94 (1993) 257-264
40. Nisbeth U., Lindh E., Ljunghall S., Backman U., and Fellstrom B. Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 67 (1999) 1218-1222